BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 32894819)

  • 1. Financial toxicity in patients with cancer attending a public Australian tertiary hospital: A pilot study.
    McLean L; Hong W; McLachlan SA
    Asia Pac J Clin Oncol; 2021 Jun; 17(3):245-252. PubMed ID: 32894819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring financial toxicity in Australian cancer patients - Validation of the COmprehensive Score for financial Toxicity (FACT COST) measuring financial toxicity in Australian cancer patients.
    Durber K; Halkett GK; McMullen M; Nowak AK
    Asia Pac J Clin Oncol; 2021 Aug; 17(4):377-387. PubMed ID: 33567158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EORTC Quality of Life Questionnaire for cancer patients (QLQ-C30): Australian general population reference values.
    Mercieca-Bebber R; Costa DS; Norman R; Janda M; Smith DP; Grimison P; Gamper EM; King MT
    Med J Aust; 2019 Jun; 210(11):499-506. PubMed ID: 31155722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study.
    Huntington SF; Weiss BM; Vogl DT; Cohen AD; Garfall AL; Mangan PA; Doshi JA; Stadtmauer EA
    Lancet Haematol; 2015 Oct; 2(10):e408-16. PubMed ID: 26686042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unmeasured costs of a child's death: perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer.
    Dussel V; Bona K; Heath JA; Hilden JM; Weeks JC; Wolfe J
    J Clin Oncol; 2011 Mar; 29(8):1007-13. PubMed ID: 21205758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Korean Version of the COmprehensive Score for financial Toxicity (COST) Among Breast Cancer Survivors.
    Shim S; Kang D; Kim N; Han G; Lim J; Kim H; Park J; Lee M; Lee JE; Kim SW; Yu J; Chae BJ; Ryu JM; Nam SJ; Lee SK; Cho J
    Cancer Res Treat; 2022 Jul; 54(3):834-841. PubMed ID: 34645130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Economic Impact on Australian Patients with Neuroendocrine Tumours.
    Gordon LG; Elliott TM; Wakelin K; Leyden S; Leyden J; Michael M; Pavlakis N; Mumford J; Segelov E; Wyld DK
    Patient; 2020 Jun; 13(3):363-373. PubMed ID: 32072460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).
    de Souza JA; Yap BJ; Wroblewski K; Blinder V; Araújo FS; Hlubocky FJ; Nicholas LH; O'Connor JM; Brockstein B; Ratain MJ; Daugherty CK; Cella D
    Cancer; 2017 Feb; 123(3):476-484. PubMed ID: 27716900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Financial Toxicity After Cancer in a Setting With Universal Health Coverage: A Call for Urgent Action.
    Bhoo-Pathy N; Ng CW; Lim GC; Tamin NSI; Sullivan R; Bhoo-Pathy NT; Abdullah MM; Kimman M; Subramaniam S; Saad M; Taib NA; Chang KM; Goh PP; Yip CH
    J Oncol Pract; 2019 Jun; 15(6):e537-e546. PubMed ID: 31112479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between financial toxicity and health-related quality of life of patients with gynecologic cancer.
    Kajimoto Y; Honda K; Suzuki S; Mori M; Tsubouchi H; Nakao K; Azuma A; Shibutani T; Nagao S; Koyanagi T; Kohara I; Tamaki S; Yabuki M; Teng L; Fujiwara K; Igarashi A
    Int J Clin Oncol; 2023 Mar; 28(3):454-467. PubMed ID: 36648710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.
    Ng MSN; Choi KC; Chan DNS; Wong CL; Xing W; Ho PS; Au C; Chan M; Tong M; Ling WM; Chan M; Mak SSS; Chan RJ; So WKW
    Support Care Cancer; 2021 Oct; 29(10):6109-6117. PubMed ID: 33797583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the Relationship between Breast Reconstruction Subtype and Risk of Financial Toxicity: A Single-Institution Pilot Study.
    Bailey CM; Asaad M; Boukovalas S; Lin YL; Kothamasu V; Kapur SK; Villa MT; Butler CE; Offodile AC
    Plast Reconstr Surg; 2021 Jul; 148(1):1e-11e. PubMed ID: 34181599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the Relationship between Socio-demographic, Clinical Profile and Financial Toxicity: Evidence from Cancer Survivors in Sarawak.
    Yap SL; Wong SS; Chew KS; Kueh JS; Siew KL
    Asian Pac J Cancer Prev; 2020 Oct; 21(10):3077-3083. PubMed ID: 33112570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Financial Toxicity of Radiation Oncology Patients Using the Validated Comprehensive Score for Financial Toxicity as a Patient-Reported Outcome.
    D'Rummo KA; Miller L; TenNapel MJ; Shen X
    Pract Radiat Oncol; 2020; 10(5):e322-e329. PubMed ID: 31634632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The association of financial difficulties and out-of-pocket payments with health-related quality of life among breast, prostate and colorectal cancer patients.
    Koskinen JP; Färkkilä N; Sintonen H; Saarto T; Taari K; Roine RP
    Acta Oncol; 2019 Jul; 58(7):1062-1068. PubMed ID: 30943813
    [No Abstract]   [Full Text] [Related]  

  • 16. Do patients with haematological malignancies suffer financial burden? A cross-sectional study of patients seeking care through a publicly funded healthcare system.
    Parker C; Ayton D; Zomer E; Liew D; Vassili C; Fong CY; Wei A
    Leuk Res; 2022 Jan; 112():106748. PubMed ID: 34798569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease-Modifying Treatment.
    Kiely F; Cran A; Finnerty D; O'Brien T
    Am J Hosp Palliat Care; 2017 Aug; 34(7):671-676. PubMed ID: 27141015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer.
    Thom B; Benedict C
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):236-242. PubMed ID: 30817217
    [No Abstract]   [Full Text] [Related]  

  • 19. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A national cross-sectional survey of financial toxicity among bladder cancer patients.
    Ehlers M; Bjurlin M; Gore J; Pruthi R; Narang G; Tan R; Nielsen M; Zhu A; Deal A; Smith A
    Urol Oncol; 2021 Jan; 39(1):76.e1-76.e7. PubMed ID: 33268274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.